Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Use of alpha-lipoic acid in prevention of contrast-induced nephropathy in diabetic patients.

Cicek M, Yıldırır A, Okyay K, Yazici AC, Aydinalp A, Kanyilmaz S, Muderrisoglu H.

Ren Fail. 2013;35(5):748-53. doi: 10.3109/0886022X.2013.790298. Epub 2013 May 7.

PMID:
23650950
2.

Alpha-lipoic acid for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography: the ALIVE study - a prospective randomized trial.

Jo SH, Kim SA, Kim HS, Han SJ, Park WJ, Choi YJ.

Cardiology. 2013;126(3):159-66. doi: 10.1159/000353812. Epub 2013 Aug 29.

PMID:
23988855
3.

Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.

Dvoršak B, Kanič V, Ekart R, Bevc S, Hojs R.

Ther Apher Dial. 2013 Aug;17(4):384-90. doi: 10.1111/1744-9987.12083.

PMID:
23931876
4.

Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.

Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.

Minerva Cardioangiol. 2010 Feb;58(1):35-40.

PMID:
20145594
5.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
6.

Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.

Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H.

J Interv Cardiol. 2013 Feb;26(1):90-6. doi: 10.1111/j.1540-8183.2012.00767.x. Epub 2012 Sep 20.

PMID:
22994682
10.

Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.

Uddin MA, Rabbani MA, Jafary FH, Bhatti MA, Islam M.

J Coll Physicians Surg Pak. 2005 Dec;15(12):791-4.

PMID:
16398973
11.

Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.

Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.

Int J Cardiol. 2010 Feb 4;138(3):239-45. doi: 10.1016/j.ijcard.2008.08.013. Epub 2008 Sep 14.

PMID:
18793808
12.

Prevention of contrast-induced nephropathy with ascorbic acid.

Zhou L, Chen H.

Intern Med. 2012;51(6):531-5. Epub 2012 Mar 15.

13.

Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?

Altunoren O, Balli M, Eren N, Tasolar H, Arpaci A, Caglayan CE, Yavuz YC, Gungor O.

Kidney Blood Press Res. 2015;40(5):533-41. doi: 10.1159/000368529. Epub 2015 Oct 25.

14.

Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.

Bilasy ME, Oraby MA, Ismail HM, Maklady FA.

J Interv Cardiol. 2012 Aug;25(4):404-10. doi: 10.1111/j.1540-8183.2012.00730.x. Epub 2012 May 22.

PMID:
22612071
15.

Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.

Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schömig A, Classen M.

Am J Cardiol. 2003 May 15;91(10):1157-62.

PMID:
12745095
16.

Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.

Wacker-Gußmann A, Bühren K, Schultheiss C, Braun SL, Page S, Saugel B, Schmid S, Mair S, Schoemig A, Schmid RM, Huber W.

AJR Am J Roentgenol. 2014 Feb;202(2):452-8. doi: 10.2214/AJR.13.10688.

PMID:
24450691
17.

N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.

Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.

Am Heart J. 2009 Mar;157(3):576-83. doi: 10.1016/j.ahj.2008.11.010. Epub 2009 Feb 6.

PMID:
19249432
18.

Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.

J Am Coll Cardiol. 2008 Aug 19;52(8):599-604. doi: 10.1016/j.jacc.2008.05.026.

19.

Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.

Gomes VO, Lasevitch R, Lima VC, Brito FS Jr, Perez-Alva JC, Moulin B, Arruda A, Oliveira D, Caramori P.

Arq Bras Cardiol. 2012 Dec;99(6):1129-34. Epub 2012 Nov 27. English, Portuguese.

20.

Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.

Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G.

J Assoc Physicians India. 2006 Jun;54:449-52.

PMID:
16909692

Supplemental Content

Support Center